Menu
Back to Journals » Drug Design, Development and Therapy » Volume 15
Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy [Corrigendum]
Zhang X, Deng Y, Xiang J, et al. Drug Des Devel Ther. 2020;14:3393–3405.
The authors have advised that the Acknowledgments statement before the Disclosure section was missed on page 3404 of the published paper. The Acknowledgments statement should read as follows:
Acknowledgments
This work was supported by Youth Program of National Natural Science Foundation of China (21708050), Hunan Provincial Health Committee’s General Subsidy Project (20200100), General Program of National Natural Science Foundation of China (8187032317) and In-hospital Youth Fund of Xiangya Hospital of Central South University (2015Q03).
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.